Capmatinib improves insulin sensitivity and inflammation in palmitate-treated C2C12 myocytes through the PPARδ/p38-dependent pathway

Publication date: Available online 11 June 2021Source: Molecular and Cellular EndocrinologyAuthor(s): Tae Woo Jung, Hyun Jung Lee, Do Hyeon Pyun, Tae Jin Kim, Joon Seok Bang, Jin-Ho Song, Yong Kyoo Shin, A.M. Abd El-Aty, Ji Hoon Jeong
Source: Molecular and Cellular Endocrinology - Category: Endocrinology Source Type: research
More News: Endocrinology | Insulin